Tripartite Meeting in Gene and Cell Therapy, 2008: Irish Society for Gene and Cell Therapy, British Society for Gene Therapy, and International Society for Cell and Gene Therapy of Cancer

被引:2
|
作者
Guinn, Barbara [1 ]
Casey, Garrett [2 ,3 ]
Collins, Sara [2 ,3 ]
O'Brien, Tim [4 ]
Alexander, M. Yvonne [5 ]
Tangney, Mark [2 ,3 ]
机构
[1] Kings Coll London, Sch Med, Rayne Inst, Dept Haematol Med, London SE5 9NU, England
[2] Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Mercy Univ Hosp, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Leslie C Quick Jr Lab, Cork, Ireland
[4] Natl Univ Ireland, Regenerat Med Inst, Galway, Ireland
[5] Univ Manchester, Sch Med, Cardiovasc Grp, Manchester M13 9NT, Lancs, England
基金
爱尔兰科学基金会;
关键词
D O I
10.1089/hum.2008.085
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland on May 15 and 16, 2008 (http://crr.ucc.ie/isgct/). The meeting was jointly organized with the British Society for Gene Therapy and the International Society for Cell and Gene Therapy of Cancer. Because of the location of the conference and the co-organization of this meeting with the British and International Gene Therapy societies, the meeting enjoyed a range of talks from some of the major leaders in the field. Particularly notable were the talented molecular and cell biologists from Ireland who have contributed cutting edge science to the field of gene therapy. Topics including cardiovascular disease, repair of single-gene disorders, and cancer gene therapy were discussed with presentations ranging from basic research to translation into the clinic. Here we describe some of the most exciting presentations and their potential impact on imminent clinical gene therapy trials.
引用
收藏
页码:967 / 978
页数:12
相关论文
共 50 条
  • [41] Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation
    Leonard, Alexis
    Bertaina, Alice
    Bonfim, Carmem
    Cohen, Sandra
    Prockop, Susan
    Purtill, Duncan
    Russell, Athena
    Boelens, Jaap Jan
    Wynn, Robert
    Ruggeri, Annalisa
    Abraham, Allistair
    CYTOTHERAPY, 2022, 24 (03) : 249 - 261
  • [42] Breast cancer: Cell and gene therapy
    Lebkowski, JS
    Philip, R
    Okarma, TB
    CANCER INVESTIGATION, 1997, 15 (06) : 568 - 576
  • [43] Gene and cell therapy for pancreatic cancer
    Singh, Hans Martin
    Ungerechts, Guy
    Tsimberidou, Apostolia M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (04) : 505 - 516
  • [44] Austratasian gene therapy society kicks off
    Alexander, I
    JOURNAL OF GENE MEDICINE, 2002, 4 (01): : 4 - 4
  • [45] THE IMPACT OF GENE-THERAPY ON MEDICINE AND SOCIETY
    KELLEY, WN
    GENE THERAPY FOR NEOPLASTIC DISEASES, 1994, 716 : 12 - 19
  • [46] The Japan Society of Gene Therapy (JS']JSGT) joins forces with other gene therapy societies
    Asano, S
    JOURNAL OF GENE MEDICINE, 2002, 4 (01): : 3 - 3
  • [47] To: Aastrom for: Cell therapy, gene therapy products
    不详
    BIOTECHNOLOGY LAW REPORT, 1999, 18 (04) : 344 - 344
  • [48] Cancer gene therapy: new horizons in the EastInternational Society for Cancer Gene Therapy, Singapore, 20–22 February 2004
    Farzin Farzaneh
    Nagy Habib
    Peter Walden
    Cancer Immunology, Immunotherapy, 2004, 53 (11) : 1052 - 1053
  • [50] European Society of Gene and Cell Therapy (ESGCT)-27th Annual Congress
    Moscoso, M.
    Toldra, J.
    DRUGS OF THE FUTURE, 2019, 44 (12) : 983 - 986